Philip Morris International's Efforts in Substituting Traditional Cigarettes with Alternatives

Oct.16.2024

PMI's parent company makes significant progress in replacing traditional cigarettes with smoke-free alternatives in the Philippines.

According to a report from MlaStandard, Philip Morris International, the parent company of PMFTC Inc., has made significant progress in their efforts to replace traditional cigarettes with smoke-free alternatives.

PMI, through its local subsidiary PMFTC Inc., launched the IQOS product in the Philippines in 2020. The product line now includes the latest version of IQOS Iluma and its disposable heating pods, TEREA. In 2022, IQOS introduced the more affordable heated tobacco product BONDS and its disposable pods, BLENDS. In 2023, the nicotine pouch product ZYN was also launched in the Philippines.

PMI's CEO Olczak stated that the company has never regarded IQOS as a supplement to its existing business, but rather as an alternative to traditional cigarettes.

Altria Group recognizes that in their efforts to provide better alternatives for the 1.1 billion smokers worldwide, they are aware that people have different expectations and usage patterns for these alternatives. "There is no one-size-fits-all smoker profile. Therefore, our duty is to constantly innovate," he added.

References:

[1] PMI reports major turning point in smoke-free transition

Also Read:

[1] Philippines DTI: Unregulated E-cigarette Products Flood Market, Urges Legal Purchases

[2] Philippine Customs intercepts illegal shipment of marijuana e-cigarettes

[3] Philippine Customs Seizes $120M Worth of Smuggled e-Cigarettes

[4] Revised Regulations on Nicotine and Non-Nicotine Vaping Products

[5] Philippine Airline bans Chinese passenger for smoking on flight

#Asia #Market #Philippines #Heated tobacco products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most

In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.

Oct.21

Pakistan Speeds Up Local Nicotine Pouch Production as PMI Unit Prepares to Launch ZYN

Pakistan’s smokeless, tobacco-free nicotine pouch market has expanded rapidly in recent years, prompting major tobacco companies to accelerate local investments, with Philip Morris Pakistan Ltd. (PMPKL) set to produce ZYN at its Sahiwal facility.

Dec.05 by 2FIRSTS.ai

Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake

As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.

Nov.03

Luxembourg Passes Bill 8333: Heated Tobacco and Nicotine Pouches Regulated

Luxembourg’s Chamber of Deputies adopted Bill No. 8333, transposing EU Directive 2022/2100 and extending tobacco controls to heated tobacco, e-cigarettes and nicotine pouches. The law bans flavourings, restricts sales to minors, and caps nicotine content at 0.048 mg per pouch. CBD and caffeine additives are prohibited.